Gwen Lapham, PhD, MPH
"My research focuses on primary care, currently in two areas: understanding cannabis use and integration of mental health services for adolescents."
Gwen Lapham, PhD, MPH, MSW
Associate Investigator, Kaiser Permanente Washington Health Research Institute
Assistant Professor, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine
Gwen.T.Lapham@kp.org
206-287-2021
Biography
Gwen Lapham, PhD, MPH, MSW, joined Kaiser Permanente Washington Health Research Institute (KPWHRI) in 2013 as an addictions health services researcher. Since then, she has capitalized on her prior social work and health services training to do impactful research on evidence-based primary care for unhealthy substance use, including alcohol, cannabis, and opioids. She has recently begun making strides in understanding cannabis use among primary care patients, including medical use and use among prenatal women.
Dr. Lapham recently completed the CATALyST K12 Washington Learning Health System Program funded by the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute. In the program, she partnered with Kaiser Permanente Washington health system leaders and with KPWHRI’s Center for Accelerating Care Transformation to address gaps in the quality of behavioral health care for children and adolescents by developing and testing an integrated approach to adolescent mental health. She expects this work to lead to new evidence for effective implementation of adolescent mental health integrated in primary care.
She is also a co-investigator of the Primary Care Opioid Use Disorders Treatment, or PROUD trial, a pragmatic implementation trial of nurse care management for treatment of opioid use disorders in primary care, as well as the Health Systems node of the National Institute on Drug Abuse Clinical Trials Network. Dr. Lapham’s research projects specific to cannabis include:
- A pilot study about the prevalence of and reasons for cannabis use among pregnant women. This study uses both cannabis screening results from the electronic health record (EHR) and qualitative interviews.
- Site principal investigator for a multisite study that examined patient-level and system-level factors associated with the Healthcare Effectiveness Data and Information Set, commonly known as HEDIS, to measure performance for initiation and engagement in treatment for patients with cannabis use disorders.
- Co-principal investigator for a study evaluating EHR documentation of medical use of cannabis. This study employs natural language processing methods to compare EHR data with data from confidential surveys about medical cannabis use.
Prior to working at KPWHRI, Dr. Lapham focused on qualitative and quantitative evaluation of preventive alcohol interventions in medical settings at the Veterans Health Administration in Seattle.
RESEARCH INTERESTS AND EXPERIENCE
-
Behavior Change
-
Addictions & Unhealthy Substance Use
-
Health Services & Economics
Implementation research; quality measurement
-
Implementation Research
Screening and brief intervention; mental health quality measurement
-
Child & Adolescent Health
-
Addictions
Prevention and treatment
Sparc trial tools
Resources for behavioral health integration
The SPARC trial successfully implemented behavioral health care into primary care. On our website, you can access tools for behavioral health integration, as well as frequently asked questions and publications.
Recent publications
Chavez LJ, Bonny AE, Bradley KA, Lapham GT, Cooper J, Miller W, Chisolm DJ Medication Treatment and Health Care Use Among Adolescents With Opioid Use Disorder in Ohio 2020 Jul;67(1):33-39. doi: 10.1016/j.jadohealth.2020.01.016. Epub 2020-04-08. PubMed
Sayre M, Lapham GT, Lee AK, Oliver M, Bobb JF, Caldeiro RM, Bradley KA Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms 2020 Apr;35(4):1111-1119. doi: 10.1007/s11606-020-05650-3. Epub 2020-01-23. PubMed
Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJ, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter RC, Ahmedani B, Braciszewski JM, Horigian VE, Szapocznik J, Samet JH, Saxon AJ, Schwartz RP, Bradley KA Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems 2020 Mar;112S:41-48. doi: 10.1016/j.jsat.2020.02.001. PubMed
Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, PROUD Collaborative Investigators Prevalence and treatment of opioid use disorders among primary care patients in six health systems 2020 Feb;207:107732. doi: 10.1016/j.drugalcdep.2019.107732. Epub 2019-11-15. PubMed
Williams EC, Bobb JF, Lee AK, Ludman EJ, Richards JE, Hawkins EJ, Merrill JO, Saxon AJ, Lapham GT, Matson TE, Chavez LJ, Caldeiro R, Greenberg DM, Kivlahan DR, Bradley KA Effect of a Care Management Intervention on 12-Month Drinking Outcomes Among Patients With and Without DSM-IV Alcohol Dependence at Baseline 2019 Aug 20 doi: 10.1007/s11606-019-05261-7. PubMed
Williams EC, McGinnis KA, Tate JP, Matson TE, Rubinsky AD, Bobb JF, Lapham GT, Edelman EJ, Catz SL, Satre DD, Bryant KJ, Marshall BDL, Kraemer KL, Bensley KM, Richards JE, Skanderson M, Justice AC, Fiellin DA, Bradley KA HIV Disease Severity is Sensitive to Temporal Changes in Alcohol Use: A National Study of VA Patients with HIV 2019 Aug;81(4):448-455. doi: 10.1097/QAI.0000000000002049. PubMed
Richards JE, Bobb JF, Lee AK, Lapham GT, Williams EC, Glass JE, Ludman EJ, Achtmeyer C, Caldeiro RM, Oliver M, Bradley KA Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: An evaluation in three pilot sites 2019 Aug;201:134-141. doi: 10.1016/j.drugalcdep.2019.04.015. Epub 2019-06-08. PubMed
Rubinsky AD, Chavez LJ, Berger D, Lapham GT, Hawkins EJ, Williams EC, Bradley KA Utility of routine alcohol screening for monitoring changes in alcohol consumption 2019 Aug;201:155-160. doi: 10.1016/j.drugalcdep.2019.03.010. Epub 2019-05-08. PubMed
Chavez LJ, Bradley KA, Lapham GT, Wickizer TM, Chisolm DJ Identifying Problematic Substance Use in a National Sample of Adolescents Using Frequency Questions 2019 Jul;32(4):550-558. doi: 10.3122/jabfm.2019.04.180284. PubMed
Bensley KM, Fortney J, Chan G, Dombrowski JC, Ornelas I, Rubinsky AD, Lapham GT, Glass JE, Williams EC Differences in Receipt of Alcohol-Related Care Across Rurality Among VA Patients Living With HIV With Unhealthy Alcohol Use 2019 Jun;35(3):341-353. doi: 10.1111/jrh.12345. Epub 2019-01-31. PubMed
Research
A single question helps identify patients at higher risk of cannabis use disorder
1 in 5 people who use cannabis daily at risk for moderate to severe use disorder.
Research
A better approach to prevent teen suicide deaths
New grant funds crucial work to test effectiveness of teen suicide prevention in primary care.
News
Training scientists to transform health care
Five years and 8 scholars later, KPWHRI celebrates the impact of the CATALyST training program on early-career scientists.
Research
Increasing opioid use disorder treatment in primary care
A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.
Research
Is medical use of cannabis as risky as nonmedical use?
New findings indicate medical cannabis use is associated with a lower risk of moderate to severe cannabis use disorder.
KPWHRI In the media
Improving opioid use disorder treatment with nurse care management
Nurses, access to medication expand treatment for opioid use disorder
Medscape, Dec. 19, 2024
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.